Siegel M D, Zhang D H, Ray P, Ray A
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
J Biol Chem. 1995 Oct 13;270(41):24548-55. doi: 10.1074/jbc.270.41.24548.
Interleukin-5 (IL-5) plays a central role in the growth and differentiation of eosinophils and contributes to several disease states including asthma. Accumulating evidence suggests a role for cAMP as an immunomodulator; agents that increase intracellular cAMP levels have been shown to inhibit production of cytokines predominantly produced by T helper (Th) 1 cells such as IL-2 and interferon gamma (IFN-gamma). In contrast, the production of IL-5, predominantly produced by Th2 cells, is actually enhanced by these agents. In this report, we have performed transient transfection experiments with IL-5 promoter-reporter gene constructs, DNase I footprinting assays, and electrophoretic mobility shift assays to investigate the key regulatory regions necessary for activation of the IL-5 promoter by dibutyryl cAMP and phorbol esters in the mouse thymoma line EL-4. Taken together, our data demonstrate the critical importance of two sequences within the IL-5 5'-flanking region for activation by these agents in EL-4 cells: one, a highly conserved 15-base pair element present in genes expressed by Th2 cells, called the conserved lymphokine element 0 (CLE0; located between -53 and -39 in the IL-5 promoter), and the other, two overlapping binding sites for the transcription factor GATA-3 (but not GATA-4) between -70 and -59. Taken together, our data suggest that activation via the unique sequence combination GATA/CLE0 results in selective expression of the IL-5 gene in response to elevated levels of intracellular cAMP.
白细胞介素-5(IL-5)在嗜酸性粒细胞的生长和分化中起核心作用,并与包括哮喘在内的多种疾病状态有关。越来越多的证据表明环磷酸腺苷(cAMP)作为一种免疫调节剂发挥作用;已显示增加细胞内cAMP水平的药物可抑制主要由辅助性T(Th)1细胞产生的细胞因子如IL-2和干扰素γ(IFN-γ)的产生。相比之下,主要由Th2细胞产生的IL-5的产生实际上被这些药物增强。在本报告中,我们用IL-5启动子-报告基因构建体进行了瞬时转染实验、DNA酶I足迹分析和电泳迁移率变动分析,以研究在小鼠胸腺瘤细胞系EL-4中,二丁酰cAMP和佛波酯激活IL-5启动子所需的关键调控区域。综合来看,我们的数据证明了IL-5 5'侧翼区域内的两个序列对于这些药物在EL-4细胞中的激活至关重要:一个是Th2细胞表达基因中存在的高度保守的15个碱基对元件,称为保守淋巴因子元件0(CLE0;位于IL-5启动子的-53至-39之间),另一个是转录因子GATA-3(而非GATA-4)在-70至-59之间的两个重叠结合位点。综合来看,我们的数据表明,通过独特的序列组合GATA/CLE0激活可导致IL-5基因在细胞内cAMP水平升高时选择性表达。